Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

0.7210

-0.0342 (-4.53%)

At close: Mar 28, 2025, 4:00 PM

0.7278

+0.0068 (0.94%)

After-hours: Mar 28, 2025, 4:33 PM EDT

Seres Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	-	-	-	144.93	33.22	Upgrade
Revenue Growth (YoY)	-	-	-	336.33%	-3.74%	Upgrade
Cost of Revenue	14.53	19.34	13.43	141.89	90.57	Upgrade
Gross Profit	-14.53	-19.34	-13.43	3.04	-57.36	Upgrade
Selling, General & Admin	53.18	77.5	70.26	69.26	30.78	Upgrade
Research & Development	53.6	98.26	96.22	-	-	Upgrade
Other Operating Expenses	-	-	-	-1.73	-	Upgrade
Operating Expenses	106.79	175.76	166.49	67.53	30.78	Upgrade
Operating Income	-121.32	-195.1	-179.91	-64.49	-88.13	Upgrade
Interest Expense	-	-2.47	-6.02	-2.91	-2.92	Upgrade
Interest & Investment Income	3.97	7.3	3.06	2.87	0.95	Upgrade
Other Non Operating Income (Expenses)	9.29	-0.1	-0.02	-0.55	1.43	Upgrade
EBT Excluding Unusual Items	-108.06	-190.37	-182.89	-65.08	-88.68	Upgrade
Gain (Loss) on Sale of Investments	-	0.24	-0.69	-0.5	-0.45	Upgrade
Gain (Loss) on Sale of Assets	5.68	-	-	-	-	Upgrade
Other Unusual Items	-23.4	-	-	-	-	Upgrade
Pretax Income	-125.77	-190.13	-183.58	-65.58	-89.13	Upgrade
Earnings From Continuing Operations	-125.77	-190.13	-183.58	-65.58	-89.13	Upgrade
Earnings From Discontinued Operations	125.91	76.41	-66.58	-	-	Upgrade
Net Income	0.14	-113.72	-250.16	-65.58	-89.13	Upgrade
Net Income to Common	0.14	-113.72	-250.16	-65.58	-89.13	Upgrade
Shares Outstanding (Basic)	155	128	108	92	80	Upgrade
Shares Outstanding (Diluted)	155	128	108	92	80	Upgrade
Shares Change (YoY)	21.40%	18.44%	17.86%	14.93%	40.85%	Upgrade
EPS (Basic)	0.00	-0.89	-2.31	-0.72	-1.12	Upgrade
EPS (Diluted)	0.00	-0.89	-2.31	-0.72	-1.12	Upgrade
Free Cash Flow	-148.99	-125.33	-238.64	-2.88	-94.2	Upgrade
Free Cash Flow Per Share	-0.96	-0.98	-2.21	-0.03	-1.18	Upgrade
Gross Margin	-	-	-	2.10%	-172.68%	Upgrade
Operating Margin	-	-	-	-44.50%	-265.33%	Upgrade
Profit Margin	-	-	-	-45.25%	-268.33%	Upgrade
Free Cash Flow Margin	-	-	-	-1.99%	-283.61%	Upgrade
EBITDA	-115.85	-188.85	-173.29	-58.55	-81.55	Upgrade
EBITDA Margin	-	-	-	-40.40%	-245.53%	Upgrade
D&A For EBITDA	5.47	6.24	6.63	5.95	6.58	Upgrade
EBIT	-121.32	-195.1	-179.91	-64.49	-88.13	Upgrade
EBIT Margin	-	-	-	-44.50%	-265.33%	Upgrade
Revenue as Reported	-	-	-	144.93	33.22	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q